Print Friendly, PDF & Email

NCT/Study#

NA /

APTEVO

Phase 1-2 Study Of A Bispecific CD3xCD123 Antibody In Acute Myeloid Leukemia Patients

DISEASE GROUP:
Leukemia
current phase:
Phase I/II
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: